Rosa V.
- Country
- Spain
- Department
- Psiquiatría
Research Overview
- Adjunctive Aticaprant and Antidepressant Therapy for Relapse Prevention in Major Depressive Disorder with Moderate-to-Severe Anhedonia: A Randomized, Double-Blind Study
- Long-term Safety and Efficacy of Aticaprant as Adjunctive Therapy in Adults and Elderly with Major Depressive Disorder: An Open-label Study
- Efficacy and Safety of Aticaprant as Adjunctive Therapy in Adults with Major Depressive Disorder and Anhedonia Unresponsive to Antidepressants
Data & Insights
Has run more than one trial at 60 of 190 partner sites.
Specializations
Depression Treatment Innovation
The investigator specializes in treating Major Depressive Disorder (MDD), with particular emphasis on developing adjunctive therapeutic approaches for patients with inadequate response to conventional antidepressants.
- Treatment-resistant depression
- Adjunctive therapy development
- SSRI/SNRI augmentation strategies
Focuses on evaluating novel therapeutic compounds as add-on treatments to existing antidepressant medications.
Specialized Depression Subtypes
Conducts research in specific manifestations of depression, particularly MDD with moderate-to-severe anhedonia and MDD with insomnia symptoms.
- Anhedonia in depression
- Sleep disorders in MDD
- Symptom-specific interventions
Investigates targeted therapeutic approaches for distinct depression subtypes and their associated symptoms.
Long-term Treatment Outcomes
Explores the long-term safety and efficacy of novel therapeutic interventions in depression treatment, with emphasis on relapse prevention strategies.
- Relapse prevention research
- Extended safety monitoring
- Treatment stability assessment
Studies sustainable treatment approaches for maintaining long-term depression remission.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.